Intravascular Access of COVID-19 Patient Under Personal Protective Equipment

Intraosseous Versus Intravenous Access During COVID-19 Patients Performed by Paramedics Wearing Level C Personal Protective Equipment. A Multi-center Prospective Randomized Crossover Single-blinded Simulation Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04366297

Enrollment

Registered

2020-04-28

Start date

2020-01-12

Completion date

2020-02-25

Last updated

2020-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Emergencies

Keywords

intravascular access, COVID-19, personal protective equipment, medical simulation

Brief summary

The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC medical personnel should be equipped with full personal protective equipment (PPE) for AGP in contact with suspected/confirmed COVID-19 patient. Therefore, it is reasonable to search for the most effective methods of intravascular access in those conditions.

Interventions

DEVICEIntravenous access

obtaining intravascular access using a standard intravenous cannula

DEVICEIntraosseous access

obtaining intravascular access using a ready intravenous NIO needle set

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* paramedic * consent voluntary participation in the study * none experience in resuscitation with personal protective equipment

Exclusion criteria

* refusal to participate in the study

Design outcomes

Primary

Measure	Time frame	Description
successful rate of first intravascular access attempt	1 day	successful placement of intravascular device

Secondary

Measure	Time frame	Description
number of attempts to successful access	1 day	number of attempts to successful access
time to infusion	1 day	time to therapy including but not limited to time to fluids, antibiotics, and antiarrythmics
time to successful access	1 day	—
ease of use	1 day	self-reported percentage the vocal cord visualization. A 100% score is a extremely difficult procedure. A Ease of use score of 1% means that procedure is extremely easy
Preferred intravascular access method	1 day	participants were asked which method of intravascular access they would prefer in a real-life resuscitation.
complication rates	1 day	complication rates

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026